My good friend at Novartis gets PC info with some regularity. This article about GenSpera's G-202 that was just approved for Phase 2 clinical trials is described as a "molecular grenade" for both slow & fast growing prostate cancer. I'm starting to believe that science will kill this darn disease sooner rather than later. One can hope. -- http://www.businesswire.com/news/home/20120731005159/en/GenSpera-Cleared-Initiate-Phase-II-G-202-Trial
My good friend at Novartis gets PC info with some regularity. This article about GenSpera's G-202 that was just approved for Phase 2 clinical trials is described as a "molecular grenade" for both slow & fast growing prostate cancer. I'm starting to believe that science will kill this darn disease sooner rather than later. One can hope. --
http://www.businesswire.com/news/home/20120731005159/en/GenSpera-Cleared-Initiate-Phase-II-G-202-Trial
Post Edited (Raddad) : 8/8/2012 8:44:21 PM (GMT-6)